$AMLX, following the Bio Techs

2022년 7월 27일

The health care industry is being leading the charge, AMLX is the proof of that. This recent IPO just broke out of a good looking cup & handle pattern. Also, IBD is giving a 99 relative strength rating.

So, I enter today with a small position. A "pilot position", as Mark Minervini would say. The market is still under pressure so I'm testing it.

As this stock is a highly volatile I'll play for a 3:1 risk/reward.

2022년 8월 11일

노트

Just put my stop loss at breakeven

2022년 8월 21일

노트

I sold my position at breakeven just be sure. The thing is that the price hasn't break support at its MAs.

I'll keep a close eye on this one for thise week's action.